Eriodictyol, a plant flavonoid, attenuates LPS-induced acute lung injury through its antioxidative and anti-inflammatory activity

Experimental and Therapeutic Medicine

Volumn 10, Issue 6, 2015, Pages 2259-2266

  Zhu, Guang Fa ^a   Guo, Hong Juan ^a   Huang, Yan ^a   Wu, Chun Ting ^a   Zhang, Xiang Feng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Acute lung injury; Eriodictyol; Lipopolysaccharide induced acute lung injury; Nuclear factor erythroid 2 related factor 2 pathway

Indexed keywords

CYTOKINE; ERIODICTYOL; LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; TRANSCRIPTION FACTOR NRF2;

ACUTE LUNG INJURY; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; LUNG LAVAGE; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84946556895     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2015.2827     Document Type: Article

References (48)

1. Luh SP and Chiang CH: Acute lung injury/acute respiratory distress syndrome (ALI/ARDS): The mechanism, present strategies and future perspectives of therapies. J Zhejiang Univ Sci B 8: 60-69, 2007.
2. Rubenfeld GD: Epidemiology of acute lung injury. Crit Care Med 31 Suppl: S276-S284, 2003.
3. Zhang X, Song K, Xiong H, Li H, Chu X and Deng X: Protective effect of florfenicol on acute lung injury induced by lipopolysaccharide in mice. Int Immunopharmacol 9: 1525-1529, 2009.
4. Ferrero-Miliani L, Nielsen OH, Andersen PS and Girardin SE: Chronic inflammation: Importance of NOD2 and NALP3 in interleukin-1beta generation. Clin Exp Immunol 147: 227-235, 2007.
5. Aderem A and Ulevitch RJ: Toll-like receptors in the induction of the innate immune response. Nature 406: 782-787, 2000.
6. Hsu H, Shu HB, Pan MG and Goeddel DV: TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84: 299-308, 1996.
7. Karin M and Lin A: NF-kappaB at the crossroads of life and death. Nat Immunol 3: 221-227, 2002.
8. Liu J, Minemoto Y and Lin A: c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis. Mol Cell Biol 24: 10844-10856, 2004.
9. Liu J and Lin A: Wiring the cell signaling circuitry by the NF-kappa B and JNK1 crosstalk and its applications in human diseases. Oncogene 26: 3267-3278, 2007.
10. Tang G, Minemoto Y, Dibling B, et al: Inhibition of JNK activation through NF-kappaB target genes. Nature 414: 313-317, 2001.
11. Aldridge AJ: Role of the neutrophil in septic shock and the adult respiratory distress syndrome. Eur J Surg 168: 204-214, 2002.
12. Martin TR: Cytokines and the acute respiratory distress syndrome (ARDS): A question of balance. Nat Med 3: 272-273, 1997.
13. Calkins MJ, Johnson DA, Townsend JA, et al: The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxid Redox Signal 11: 497-508, 2009.
14. Touyz RM: Reactive oxygen species, vascular oxidative stress and redox signaling in hypertension: What is the clinical significance? Hypertension 44: 248-252, 2004.
15. Van Eeden S, Leipsic J, Paul Man SF and Sin DD: The relationship between lung inflammation and cardiovascular disease. Am J Respir Crit Care Med 186: 11-16, 2012.
16. Cachofeiro V, Goicochea M, de Vinuesa SG, Oubiña P, Lahera V and Luño J: Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int Suppl 74: S4-S9, 2008.
17. Pedruzzi LM, Stockler-Pinto MB, Leite M, Jr and Mafra D: Nrf2-keap1 system versus NF-kappaB: The good and the evil in chronic kidney disease? Biochimie 94: 2461-2466, 2012.
18. Deramaudt TB, Dill C and Bonay M: Regulation of oxidative stress by Nrf2 in the pathophysiology of infectious diseases. Med Mal Infect 43: 100-107, 2013.
19. Ismaili H, Sosa S, Brkic D, et al: Topical anti-inflammatory activity of extracts and compounds from Thymus broussonettii. J Pharm Pharmacol 54: 1137-1140, 2002.
20. Minato K, Miyake Y, Fukumoto S, et al: Lemon flavonoid, eriocitrin, suppresses exercise-induced oxidative damage in rat liver. Life Sci 72: 1609-1616, 2003.
21. Lee JK: Anti-inflammatory effects of eriodictyol in lipopolysaccharide-stimulated raw 264.7 murine macrophages. Arch Pharm Res 34: 671-679, 2011.
22. Zhou ZH, Sun B, Lin K and Zhu LW: Prevention of rabbit acute lung injury by surfactant, inhaled nitric oxide, and pressure support ventilation. Am J Respir Crit Care Med 161: 581-588, 2000.
23. Bradley PP, Priebat DA, Christensen RD and Rothstein G: Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78: 206-209, 1982.
24. Numata M, Suzuki S, Miyazawa N, et al: Inhibition of inducible nitric oxide synthase prevents LPS-induced acute lung injury in dogs. J Immunol 160: 3031-3037, 1998.
25. Lee JP, Li YC, Chen HY, et al: Protective effects of luteolin against lipopolysaccharide-induced acute lung injury involves inhibition of MEK/ERK and PI3K/Akt pathways in neutrophils. Acta Pharmacol Sin 31: 831-838, 2010.
26. Nosotti M, Falleni M, Palleschi A, et al: Quantitative real-time polymerase chain reaction detection of lymph node lung cancer micrometastasis using carcinoembryonic antigen marker. Chest 128: 1539-1544, 2005.
27. Manicone AM, Birkland TP, Lin M, et al: Epilysin (MMP-28) restrains early macrophage recruitment in Pseudomonas aeruginosa pneumonia. J Immunol 182: 3866-3876, 2009.
28. Kabir K, Gelinas JP, Chen M, et al: Characterization of a murine model of endotoxin-induced acute lung injury. Shock 17: 300-303, 2002.
29. Abraham E: Neutrophils and acute lung injury. Crit Care Med 31 4 Suppl: S195-S199, 2003.
30. Grommes J and Soehnlein O: Contribution of neutrophils to acute lung injury. Mol Med 17: 293-307, 2011.
31. Cheng PY, Lee YM, Wu YS, Chang TW, Jin JS and Yen MH: Protective effect of baicalein against endotoxic shock in rats in vivo and in vitro. Biochem Pharmacol 73: 793-804, 2007.
32. Baldwin SR, Simon RH, Grum CM, Ketai LH, Boxer LA and Devall LJ: Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet 1: 11-14, 1986.
33. Kietzmann D, Kahl R, Müller M, Burchardi H and Kettler D: Hydrogen peroxide in expired breath condensate of patients with acute respiratory failure and with ARDS. Intensive Care Med 19: 78-81, 1993.
34. Johnson J, Maher P and Hanneken A: The flavonoid, eriodictyol, induces long-term protection in ARPE-19 cells through its effects on Nrf2 activation and phase 2 gene expression. Invest Ophthalmol Vis Sci 50: 2398-2406, 2009.
35. Wang B, Zhu X, Kim Y, et al: Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage. Free Radic Biol Med 52: 928-936, 2012.
36. Furukawa M, Tanaka R, Chuang VT, et al: Human serum albumin-thioredoxin fusion protein with long blood retention property is effective in suppressing lung injury. J Control Release 154: 189-195, 2011.
37. Frank JA, Wray CM, McAuley DF, Schwendener R and Matthay MA: Alveolar macrophages contribute to alveolar barrier dysfunction in ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol 291: L1191-L1198, 2006.
38. Eyal FG, Hamm CR and Parker JC: Reduction in alveolar macrophages attenuates acute ventilator induced lung injury in rats. Intensive Care Med 33: 1212-1218, 2007.
39. Johnston LK, Rims CR, Gill SE, McGuire JK and Manicone AM: Pulmonary macrophage subpopulations in the induction and resolution of acute lung injury. Am J Respir Cell Mol Biol 47: 417-426, 2012.
40. Matthay MA, Ware LB and Zimmerman GA: The acute respiratory distress syndrome. J Clin Invest 122: 2731-2740, 2012.
41. Rojas M, Woods CR, Mora AL, Xu J and Brigham KL: Endotoxin-induced lung injury in mice: Structural, functional and biochemical responses. Am J Physiol Lung Cell Mol Physiol 288: L333-L341, 2005.
42. Wu Y, Singer M, Thouron F, Alaoui-El-Azher M and Touqui L: Effect of surfactant on pulmonary expression of type IIA PLA(2) in an animal model of acute lung injury. Am J Physiol Lung Cell Mol Physiol 282: L743-750, 2002.
43. Jerala R: Structural biology of the LPS recognition. Int J Med Microbiol 297: 353-363, 2007.
44. Lu YC, Yeh WC and Ohashi PS: LPS/TLR4 signal transduction pathway. Cytokine 42: 145-151, 2008.
45. Goodman RB, Pugin J, Lee JS and Matthay MA: Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev 14: 523-535, 2003.
46. Manicone AM: Role of the pulmonary epithelium and inflammatory signals in acute lung injury. Expert Rev Clin Immunol 5: 63-75, 2009.
47. Ward PA: Oxidative stress: Acute and progressive lung injury. Ann NY Acad Sci 1203: 53-59, 2010.
48. Imai Y, Kuba K, Neely GG, et al: Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133: 235-249, 2008.